Latest News for: gri

Edit

Notice of Effectiveness (Form EFFECT) (Gri Bio Inc)

Public Technologies 02 Apr 2025
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549 ... GRI Bio, Inc ... Gri Bio Inc.
Edit

GRI Bio Announces Pricing of $5.0 Million Public Offering (Form 8-K) (Gri Bio Inc)

Public Technologies 02 Apr 2025
GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T ("NKT") cell modulators for the treatment of inflammatory, ...
Edit

GRI Bio Announces Closing of $5.0 Million Public Offering

Nasdaq Globe Newswire 02 Apr 2025
GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune ...
Edit

GRI 2025 Report (Ball Corporation)

Public Technologies 02 Apr 2025
This Global Reporting Initiative (GRI) Content Index supplements Ball Corporation's (Ball, we, us or our) sustainability reporting on www ... This report has been prepared in accordance with the GRI Standards ... GRI 2 GENERAL DISCLOSURES 2021.
Edit

2024 GRI Index (International Paper Company)

Public Technologies 02 Apr 2025
Global Reporting Initiative (GRI) Index. International Paper has reported the information cited in this GRI content index for the period from 1 January 2024 to 31 December 2024 with reference to the GRI Standards. GRI Indicator ... GRI Index 2024 ... GRI 3.
Edit

Supplemental Prospectus (Form 424B4) (Gri Bio Inc)

Public Technologies 02 Apr 2025
Before we can generate any revenue from sales of our lead product candidate, GRI-0621, GRI-0803 or any of our other product candidates, we must undergo additional clinical development, regulatory review, and approval in one or more jurisdictions.
Edit

GRI Bio Announces Pricing of $5.0 Million Public Offering

Nasdaq Globe Newswire 01 Apr 2025
GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune ...
Edit

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 ...

Nasdaq Globe Newswire 01 Apr 2025
The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data reviewed ... .
Edit

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan

Nasdaq Globe Newswire 31 Mar 2025
Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases ... .
Edit

Hamilton Town House will light up to raise awareness of GRI gene disorders

Daily Record 28 Mar 2025
Local mum Kristina McKean, who has helped establish a UK-based charity to provide support and research, has arranged the special event ... .
Edit

‘White Lotus’ villain Jon Gries reveals the true crimes that inspired his twisty take on Greg/Gary

CNN 28 Mar 2025
As the season has unfolded, Greg (played by Jon Gries) has emerged as an antagonist, particularly after Belinda dove into the investigation surrounding Tanya’s death and realized Greg, who now goes by Gary, evaded questioning by authorities.
Edit

Kidnapped Mom And Baby Creatures Found In Crate, 3 People Get Arrested

Opposing Views 27 Mar 2025
Note ... While they remain weak from their captivity, the DSWF-supported GRI Wildlife Crime Prevention Project has stepped in to aid in their recovery ... "They seem to be eating, which is a great sign," said Annekim Geerdes of the GRI Wildlife Vet Program.
Edit

GRI Index 2024 (Metso Oyj)

Public Technologies 26 Mar 2025
). The text version of this document is not available ... Attachments Permalink.
Edit

2015 Sustainability Disclosure & GRI Index (The Mosaic Company)

Public Technologies 26 Mar 2025
(G4-17, G4-22, G4-23, G4-32, G4-33) Our 2015 Sustainability Report is based on the Global Reporting Initiative's (GRI) G4 Guidelines 'in accordance' option core.
Edit

Amendment to Initial Registration Statement (Form S-1/A) (Gri Bio Inc)

Public Technologies 26 Mar 2025
Before we can generate any revenue from sales of our lead product candidate, GRI-0621, GRI-0803 or any of our other product candidates, we must undergo additional clinical development, regulatory review, and approval in one or more jurisdictions.
×